ImmunOs Therapeutics AG is dedicated to developing novel therapeutics that harness the immune system to treat cancer and inflammatory diseases
ImmunOs Therapeutics AG is dedicated to developing novel therapeutics that harness the immune system to treat cancer and inflammatory diseases. Their approach is based on identifying specific human leukocyte antigen (HLA) molecules to create biologic therapies that activate the immune system against tumors and autoimmune conditions.